Saudi Arabia - Re-Export of Extracts of Glands for Therapeutic Use
At $5,556.53 in 2018, the country was ranked number 3 comparing other countries in Re-Export of Extracts of Glands for Therapeutic Use. Saudi Arabia is overtaken by Georgia, which was number 2 with $73,777.45 and is followed by United Arab Emirates at $5,186.18. United States lead the ranking with $266,511 in 2019, -17.2% compared to 2018. United States witnessed the best average annual growth at +9.1% per year, while Canada recorded the worst performance at -77.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2018 | 5,556.53 |
| 2017 | 30,101.07 |
| 2016 | |
| 2015 | |
| 2014 |
Download all data from 1995 to 2018
How does Saudi Arabia rank in Re-Export of Extracts of Glands for Therapeutic Use?
| # | 6 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
266,511.00 | 2019 | -17.2 % | +9.1 % | View data |
| 2 |
#2
Georgia
|
73,777.45 | 2018 | NA | NA | View data |
| 3 |
#3
Saudi Arabia
|
5,556.53 | 2018 | -81.5 % | NA | View data |
| 4 |
#4
United Arab Emirates
|
5,186.18 | 2018 | NA | +3.4 % | View data |
| 5 |
#5
New Zealand
|
311.12 | 2018 | NA | -22.2 % | View data |